Literature DB >> 3114659

Interleukin-2-like activity in injured rat brain.

M Nieto-Sampedro, K G Chandy.   

Abstract

The lymphokine interleukin-2 (IL-2) promotes division and maturation of oligodendrocytes in culture. We now report that a IL-2-like activity was present in injured rat brain. The ion-exchange properties of this activity were similar to those of splenocyte IL-2 but its apparent molecular weight was higher. Brain IL-2-like activity was highest in the tissue immediately adjacent to the injury, reaching a maximal activity of about 8000 U/g tissue after 10 days postlesion. The mitogenic activity of injured-brain extracts on astrocytes and CTLL thymocytes was partially inhibited by monoclonal antibodies to murine IL-2 receptor. However, pure human IL-2 did not have mitogenic activity for cultured rat astrocytes. Purified astrocytes, alone or stimulated in a variety or ways, did not produce IL-2-like activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114659     DOI: 10.1007/bf00970528

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  17 in total

1.  Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.

Authors:  F M Hofman; R I von Hanwehr; C A Dinarello; S B Mizel; D Hinton; J E Merrill
Journal:  J Immunol       Date:  1986-05-01       Impact factor: 5.422

2.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

3.  The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.

Authors:  G Ortega; R J Robb; E M Shevach; T R Malek
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

4.  Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction?

Authors:  A Fontana; E Weber; J M Dayer
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  Injury-induced neuronotrophic activity in adult rat brain: correlation with survival of delayed implants in the wound cavity.

Authors:  M Nieto-Sampedro; M Manthrope; G Barbin; S Varon; C W Cotman
Journal:  J Neurosci       Date:  1983-11       Impact factor: 6.167

6.  Interleukin-1 stimulation of astroglial proliferation after brain injury.

Authors:  D Giulian; L B Lachman
Journal:  Science       Date:  1985-04-26       Impact factor: 47.728

7.  Astrocyte mitogenic activity in aged normal and Alzheimer's human brain.

Authors:  M Nieto-Sampedro
Journal:  Neurobiol Aging       Date:  1987 May-Jun       Impact factor: 4.673

8.  Dynamic aspects of glial reactions in altered brains.

Authors:  T Kitamura
Journal:  Pathol Res Pract       Date:  1980       Impact factor: 3.250

9.  Monoclonal cytolytic T-cell lines.

Authors:  P E Baker; S Gillis; K A Smith
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

10.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  3 in total

1.  Identification of an interleukin 2-like substance as a factor cytotoxic to oligodendrocytes and associated with central nervous system regeneration.

Authors:  S Eitan; R Zisling; A Cohen; M Belkin; D L Hirschberg; M Lotan; M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Differential immune responses to fetal intracameral spinal cord and cortex cerebri grafts.

Authors:  M Shinoda; M Giacobini; R Schmidt-Kastner; K Trok; L Olson
Journal:  Exp Brain Res       Date:  1996-07       Impact factor: 1.972

3.  Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury.

Authors:  A Logan; S A Frautschy; A M Gonzalez; M B Sporn; A Baird
Journal:  Brain Res       Date:  1992-08-07       Impact factor: 3.252

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.